Gritstone bio Inc GRTS:NASDAQ

Last Price$3.40Cboe Closing Price as of 4:00PM ET 8/10/22
Cboe Real-Time Quotes
Today's Change-0.08(2.16%)
Bid (Size)$2.76 (100)
Ask (Size)$4.16 (100)
Day Low / High$3.39 - 3.61
Volume1.0 M
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/10/2022

 

Gritstone bio Inc ( NASDAQ )

Price: $3.40
Change: -0.08 (2.16%)
Volume: 1.0 M
4:00PM ET 8/10/2022
 
 

Quanterix Corp ( NASDAQ )

Price: $8.54
Change: +1.08 (14.48%)
Volume: 5.0 M
4:00PM ET 8/10/2022
 
 

Evelo Biosciences Inc ( NASDAQ )

Price: $2.91
Change: +0.20 (7.38%)
Volume: 122.2 K
3:59PM ET 8/10/2022
 
 

Fulcrum Therapeutics Inc ( NASDAQ )

Price: $7.75
Change: +0.35 (4.73%)
Volume: 392.5 K
4:00PM ET 8/10/2022
 
 

Allakos Inc ( NASDAQ )

Price: $3.84
Change: +0.18 (4.92%)
Volume: 472.4 K
4:00PM ET 8/10/2022
 

Read more news Recent News

-- Earnings Flash (GRTS) GRITSTONE BIO Reports Q2 Revenue $5.5M
4:31PM ET 8/04/2022 MT Newswires

...

--HC Wainwright Lowers Gritstone bio's Price Target to $12 From $15, Maintains Buy Rating
11:24AM ET 5/09/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (GRTS) GRITSTONE BIO Posts Q1 Revenue $7.2M, vs. Street Est of $4.21M
4:48PM ET 5/05/2022 MT Newswires

...

--HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Rating
9:42AM ET 3/14/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionGritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA. View company web site for more details
Address5959 Horton Street
Emeryville, California 94608
Phone+1.510.871.6100
Number of Employees113
Recent SEC Filing08/10/20228-K
President, Chief Executive Officer & DirectorAndrew R. Allen
Chief Operating OfficerErin E. Jones
Chief Financial Officer & Executive Vice PresidentVassiliki Celia Economides
Head-Research & DevelopmentKarin Jooss

Company Highlights

Price Open$3.53
Previous Close$3.47
52 Week Range$1.71 - 14.42
Market Capitalization$247.2 M
Shares Outstanding72.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/02/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.47
Beta vs. S&P 500N/A
Revenue$1.2 M
Net Profit Margin-977.46%
Return on Equity-59.91%

Analyst Ratings as of 01/27/2021

Buy
3
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset